Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis

被引：0
|
作者：
Gary T. Ferguson
Patrick Darken
Shaila Ballal
Mohd Kashif Siddiqui
Barinder Singh
Sumeet Attri
Ulf Holmgren
Enrico de Nigris
机构：
[1] Pulmonary Research Institute of Southeast Michigan,
[2] AstraZeneca,undefined
[3] Parexel International,undefined
[4] AstraZeneca,undefined
[5] AstraZeneca,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Chronic obstructive pulmonary disease; Exacerbations; Inhaled corticosteroid; Long-acting muscarinic antagonist; Long-acting β; -agonist; Lung function; Network meta-analysis; Patient-reported outcomes; Triple therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2956 / 2975
页数：19
相关论文
共 42 条
  • [21] Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis
    Lee, Hyun Woo
    Kim, Hyung Jun
    Jang, Eun Jin
    Lee, Chang-Hoon
    RESPIRATION, 2021, 100 (07) : 631 - 643
  • [22] Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting 2-agonists: a systematic review and network meta-analysis
    Schlueter, Max
    Gonzalez-Rojas, N.
    Baldwin, Michael
    Groenke, Lars
    Voss, Florian
    Reason, Tim
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (02) : 89 - 104
  • [23] ADHERENCE TO CURRENT GUIDELINES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SUBJECTS TREATED WITH COMBINATION OF LONG-ACTING B2-AGONIST (LABA), LONG-ACTING MUSCARINIC ANTAGONIST (LAMA) OR INHALED CORTICOSTEROIDS (ICS)
    Asche, C.
    Leader, S.
    Plauschinat, C.
    Raparla, S.
    Ye, X.
    Yan, M.
    Young, D.
    VALUE IN HEALTH, 2011, 14 (07) : A492 - A492
  • [24] Adherence To Current Guidelines For Chronic Obstructive Pulmonary Disease (COPD) In Subjects Treated With Combination Of Long-Acting Beta2-Agonist (LABA), Long-Acting Muscarinic Antagonist (LAMA) Or Inhaled Corticosteroids (ics)
    Asche, C. V.
    Leader, S.
    Plauschinat, C.
    Raparla, S.
    Yan, M.
    Ye, X.
    Young, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [25] Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis
    Oba, Yuji
    Lone, Nazir A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 469 - 479
  • [26] Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis
    Oba, Yuji
    Anwer, Sumayya
    Patel, Tarang
    Maduke, Tinashe
    Dias, Sofia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (08):
  • [27] RELATIVE EFFICACY AND SAFETY OF INHALED GLYCOPYRRONIUM plus FORMOTEROL FUMARATE DIHYDRATE VERSUS OTHER LAMA plus LABA FIXED-DOSE COMBINATIONS IN COPD: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS
    Siddiqui, M. K.
    Singh, I.
    Jenkins, M.
    Darken, P.
    Guranlioglu, D.
    THORAX, 2018, 73 : A233 - A234
  • [28] ADDITIONAL EFFECT OF INHALED CORTICO STEROID (ICS) ON PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVING LONG-ACTING MUSCARINIC ANTAGONIST(LAMA)/ LONG-ACTING β2-AGONIST(LABA) - SINGLE-CENTRE, PROSPECTIVE, REAL-WORLD STUDY
    Tanaka, Yosuke
    Yajima, Chika
    Hino, Mitsunori
    Saitoh, Yozo
    Nishima, Shunichi
    Kosahira, Seiji
    Motohashi, Norihisa
    Gemma, Akihiko
    RESPIROLOGY, 2017, 22 : 178 - 178
  • [29] Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler
    Berger, William E.
    Noonan, Michael J.
    JOURNAL OF ASTHMA, 2010, 47 (04) : 447 - 459
  • [30] Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials
    Chen, Wang-Chun
    Huang, Chi-Hsien
    Sheu, Chau-Chyun
    Chong, Inn-Wen
    Chu, Kuo-An
    Chen, Yung-Che
    Tsai, Jong-Rung
    Lee, Cheng-Hung
    Wei, Yu-Feng
    RESPIROLOGY, 2017, 22 (07) : 1313 - 1319
12345